BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 26678328)

  • 1. Vitamin D, PTH and the risk of overall and disease-specific mortality: Results of the Longitudinal Aging Study Amsterdam.
    El Hilali J; de Koning EJ; van Ballegooijen AJ; Lips P; Sohl E; van Marwijk HWJ; Visser M; van Schoor NM
    J Steroid Biochem Mol Biol; 2016 Nov; 164():386-394. PubMed ID: 26678328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone with mortality among middle-aged and older European men.
    Lee DM; Vanderschueren D; Boonen S; O'Neill TW; Pendleton N; Pye SR; Ravindrarajah R; Gielen E; Claessens F; Bartfai G; Casanueva FF; Finn JD; Forti G; Giwercman A; Han TS; Huhtaniemi IT; Kula K; Lean ME; Punab M; Wu FC;
    Age Ageing; 2014 Jul; 43(4):528-35. PubMed ID: 24375224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum parathyroid hormone and 25-hydroxyvitamin D concentrations and risk of incident heart failure: the Multi-Ethnic Study of Atherosclerosis.
    Bansal N; Zelnick L; Robinson-Cohen C; Hoofnagle AN; Ix JH; Lima JA; Shoben AB; Peralta CA; Siscovick DS; Kestenbaum B; de Boer IH
    J Am Heart Assoc; 2014 Dec; 3(6):e001278. PubMed ID: 25468653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thresholds for Serum 25(OH)D Concentrations With Respect to Different Outcomes.
    Sohl E; de Jongh RT; Heymans MW; van Schoor NM; Lips P
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2480-8. PubMed ID: 25856212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community.
    Hagström E; Hellman P; Larsson TE; Ingelsson E; Berglund L; Sundström J; Melhus H; Held C; Lind L; Michaëlsson K; Arnlöv J
    Circulation; 2009 Jun; 119(21):2765-71. PubMed ID: 19451355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men.
    Cawthon PM; Parimi N; Barrett-Connor E; Laughlin GA; Ensrud KE; Hoffman AR; Shikany JM; Cauley JA; Lane NE; Bauer DC; Orwoll ES; Cummings SR;
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4625-34. PubMed ID: 20631024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone Mineral Density and Parathyroid Hormone as Independent Risk Factors for Mortality in Community-Dwelling Older Adults: A Population-Based Prospective Cohort Study in Brazil. The São Paulo Ageing & Health (SPAH) Study.
    Domiciano DS; Machado LG; Lopes JB; Figueiredo CP; Caparbo VF; Oliveira RM; Scazufca M; McClung MR; Pereira RM
    J Bone Miner Res; 2016 Jun; 31(6):1146-57. PubMed ID: 26814375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of vitamin D status and vitamin D-related polymorphisms with sex hormones in older men.
    Rafiq R; van Schoor NM; Sohl E; Zillikens MC; Oosterwerff MM; Schaap L; Lips P; de Jongh RT
    J Steroid Biochem Mol Biol; 2016 Nov; 164():11-17. PubMed ID: 26610790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women.
    Snijder MB; Lips P; Seidell JC; Visser M; Deeg DJ; Dekker JM; van Dam RM
    J Intern Med; 2007 Jun; 261(6):558-65. PubMed ID: 17547711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D, parathyroid hormone, and cardiovascular events among older adults.
    Kestenbaum B; Katz R; de Boer I; Hoofnagle A; Sarnak MJ; Shlipak MG; Jenny NS; Siscovick DS
    J Am Coll Cardiol; 2011 Sep; 58(14):1433-41. PubMed ID: 21939825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low 25-hydroxyvitamin D predicts the onset of mobility limitation and disability in community-dwelling older adults: the Health ABC Study.
    Houston DK; Neiberg RH; Tooze JA; Hausman DB; Johnson MA; Cauley JA; Bauer DC; Shea MK; Schwartz GG; Williamson JD; Harris TB; Kritchevsky SB;
    J Gerontol A Biol Sci Med Sci; 2013 Feb; 68(2):181-7. PubMed ID: 22573914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults.
    Ginde AA; Scragg R; Schwartz RS; Camargo CA
    J Am Geriatr Soc; 2009 Sep; 57(9):1595-603. PubMed ID: 19549021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam.
    Visser M; Deeg DJ; Lips P;
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5766-72. PubMed ID: 14671166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined associations of 25-hydroxivitamin D and parathyroid hormone with diabetes risk and associated comorbidities among U.S. white and black women.
    Xia J; Tu W; Manson JE; Nan H; Shadyab AH; Bea JW; Gower EW; Qi L; Cheng TD; Song Y
    Nutr Diabetes; 2021 Sep; 11(1):29. PubMed ID: 34531372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults.
    Hoogendijk WJ; Lips P; Dik MG; Deeg DJ; Beekman AT; Penninx BW
    Arch Gen Psychiatry; 2008 May; 65(5):508-12. PubMed ID: 18458202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathormone, vitamin D and the risk of atrial fibrillation in older adults: A prospective study.
    Trevisan C; Piovesan F; Lucato P; Zanforlini BM; De Rui M; Maggi S; Noale M; Corti MC; Perissinotto E; Manzato E; Sergi G
    Nutr Metab Cardiovasc Dis; 2019 Sep; 29(9):939-945. PubMed ID: 31303477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women.
    Snijder MB; van Dam RM; Visser M; Deeg DJ; Dekker JM; Bouter LM; Seidell JC; Lips P
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4119-23. PubMed ID: 15855256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inverse association between serum 25-hydroxyvitamin D and mortality may be modified by vitamin A status and use of vitamin A supplements.
    Schmutz EA; Zimmermann MB; Rohrmann S
    Eur J Nutr; 2016 Feb; 55(1):393-402. PubMed ID: 25701092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study.
    Drechsler C; Verduijn M; Pilz S; Dekker FW; Krediet RT; Ritz E; Wanner C; Boeschoten EW; Brandenburg V;
    Nephrol Dial Transplant; 2011 Mar; 26(3):1024-32. PubMed ID: 20947538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons.
    Kuchuk NO; Pluijm SM; van Schoor NM; Looman CW; Smit JH; Lips P
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1244-50. PubMed ID: 19158198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.